ERBB2 and neoplasm: The expression of GLI1, Shh and NF-κB correlated with clinico-pathological variables including histological type, tumor grade, tumor size, lymph node metastasis, and EGFR, ErbB2, estrogen receptor (ER) and progesterone receptor (PR) expression (Table 1).